再発寛解型多発性硬化症(RRMS)治療のグローバル臨床試験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Relapsing Remitting Multiple Sclerosis (RRMS) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Relapsing Remitting Multiple Sclerosis (RRMS) to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Relapsing Remitting Multiple Sclerosis (RRMS) to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Relapsing Remitting Multiple Sclerosis (RRMS) 26
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Relapsing Remitting Multiple Sclerosis (RRMS) Therapeutics Clinical Trials 34
Prominent Drugs 35
Latest Clinical Trials News on Relapsing Remitting Multiple Sclerosis (RRMS) 36
Apr 29, 2014: Synthetic Biologics Reports University of California, Los Angeles Announcement Of Preliminary Positive Topline Efficacy And Safety Results From Investigator-Led Phase 2 Study Of Trimesta For Relapsing-Remitting Multiple Sclerosis 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Biogen Idec Inc. 37
Clinical Trial Overview of Biogen Idec Inc. 37
Novartis AG 42
Clinical Trial Overview of Novartis AG 42
E. Merck KG 45
Clinical Trial Overview of E. Merck KG 45
Teva Pharmaceutical Industries Limited 48
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 48
Bayer AG 51
Clinical Trial Overview of Bayer AG 51
Sanofi 53
Clinical Trial Overview of Sanofi 53
GlaxoSmithKline plc 54
Clinical Trial Overview of GlaxoSmithKline plc 54
Merck & Co., Inc. 55
Clinical Trial Overview of Merck & Co., Inc. 55
Pfizer Inc. 56
Clinical Trial Overview of Pfizer Inc. 56
Actelion Ltd 57
Clinical Trial Overview of Actelion Ltd 57
Clinical Trial Overview of Top Institutes / Government 58
Charite – Universitatsmedizin Berlin 58
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 58
Tehran University of Medical Sciences 59
Clinical Trial Overview of Tehran University of Medical Sciences 59
Johns Hopkins University 60
Clinical Trial Overview of Johns Hopkins University 60
University of Southern California 61
Clinical Trial Overview of University of Southern California 61
Cantonal Hospital 62
Clinical Trial Overview of Cantonal Hospital 62
University at Buffalo School of Medicine and Biomedical Sciences 63
Clinical Trial Overview of University at Buffalo School of Medicine and Biomedical Sciences 63
University of California, San Francisco 64
Clinical Trial Overview of University of California, San Francisco 64
University of Wisconsin Madison 65
Clinical Trial Overview of University of Wisconsin Madison 65
National Institute of Neurological Disorders and Stroke 66
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 66
University Hospital Inselspital, Berne 67
Clinical Trial Overview of University Hospital Inselspital, Berne 67
Five Key Clinical Profiles 68
Appendix 125
Abbreviations 125
Definitions 125
Research Methodology 126
Secondary Research 126
About GlobalData 127
Contact Us 127
Disclaimer 127
Source 127